Skip to main content
Premium Trial:

Request an Annual Quote

Interpace Dx Gets Additional Time to Comply With Nasdaq Listing Requirements

NEW YORK (GenomeWeb) – Interpace Diagnostics has received notification from Nasdaq that it has been granted an additional 180 days to come into compliance with listing requirements for the exchange, the firm said in a document filed today with the US Securities and Exchange Commission.

The Parsippany, New Jersey-based firm received notice from Nasdaq in January 2016 that it did not meet the minimum bid price requirement for continued listing on the Nasdaq Capital Market.

The firm was given until July 5 to regain compliance, however, Nasdaq has extended the deadline for 180 days. Interpace now has until Jan. 3, 2017 to regain compliance with the minimum $1.00 per share bid requirement. The firm is otherwise in compliance for listing.

Interpace said in the document that it may regain compliance with listing requirements through a reverse stock split, if necessary.

Interpace, formerly known as PDI, is currently undergoing a restructuring to become a "pure-play" diagnostics company, and in March it cut 18 employees as part of that effort. The firm offers pancreatic cyst and thyroid cancer molecular testing.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.